Walleye Trading LLC Compass Pathways PLC Call Options Transaction History

Walleye Trading LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	N/A	245,200 Added 5108.33%	250,000 $2.14 Million
Q1 2024 May 15, 2024	SELL	N/A	-65,400 Reduced 93.16%	4,800 $40,000
Q3 2023 Nov 14, 2023	SELL	N/A	-900 Reduced 1.27%	70,200 $599,000
Q2 2023 Aug 14, 2023	SELL	$7.79 - $10.69 $11,685 - $16,035	-1,500 Reduced 2.07%	71,100 $607,000
Q1 2023 May 15, 2023	BUY	$7.32 - $10.85 $10,980 - $16,275	1,500 Added 2.11%	72,600 $720,000
Q4 2022 Feb 14, 2023	SELL	$7.84 - $11.68 $299,488 - $446,176	-38,200 Reduced 34.95%	71,100 $570,000
Q3 2022 Nov 14, 2022	BUY	$10.73 - $20.07 $265,031 - $495,729	24,700 Added 29.2%	109,300 $1.17 Million
Q2 2022 Aug 08, 2022	SELL	$6.76 - $14.18 $267,020 - $560,110	-39,500 Reduced 31.83%	84,600 $915,000
Q1 2022 May 16, 2022	BUY	$11.13 - $23.04 $967,197 - $2 Million	86,900 Added 233.6%	124,100 $1.6 Million
Q4 2021 Feb 14, 2022	BUY	$21.81 - $48.96 $438,381 - $984,096	20,100 Added 117.54%	37,200 $822,000
Q2 2021 Aug 16, 2021	BUY	$32.29 - $39.68 $552,159 - $678,528	17,100 New	17,100 $652,000

151

33.6M

536K

582K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.